Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,225Revenue (TTM) $M507Net Margin (%)10.2Altman Z-Score3.6
Enterprise Value $M1,222EPS (TTM) $1.1Operating Margin %16.0Piotroski F-Score4
P/E(ttm)28.5Beneish M-Score-2.5Pre-tax Margin (%)14.8Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %8.0Quick Ratio4.1Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %28.1Current Ratio4.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-21.8ROA % (ttm)5.1Higher Current Ratio y-yN
Dividend Yield %--PEG1.2ROE % (ttm)8.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.0ROIC % (ttm)8.7Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

EBS is held by these investors:



EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Havey AdamEVP, Biodefense Divison 2017-04-03Sell11,419$28.624.51view
Hauer Jerome MDirector 2017-03-08Sell2,576$31.27-4.35view
Bailey SueDirector 2017-01-17Sell19,424$29.780.44view
Havey AdamEVP, Biodefense Divison 2017-01-17Sell8,438$29.750.54view
Abdun-Nabi DanielPresident and CEO 2017-01-10Sell28,240$31.28-4.38view
Richard RonaldDirector 2016-12-13Sell5,900$34.09-12.26view
JOULWAN GEORGE ADirector 2016-06-06Sell4,700$44.12-32.21view
Abdun-Nabi DanielPresident & CEO 2016-06-01Sell8,699$43.74-31.62view
El-Hibri FuadChairman, 10% Owner 2016-05-27Sell9,835$43.5-31.24view
El-Hibri FuadChairman, 10% Owner 2016-05-26Sell39,759$43.13-30.65view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call Apr 20 2017 
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botuli Mar 31 2017 
Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic N Mar 17 2017 
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral Hemor Feb 13 2017 
Emergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a C Feb 09 2017 
Emergent BioSolutions Initiates NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum Anti Feb 01 2017 
Emergent BioSolutions Receives German Federal Ministry of Health Approval of Building 55 for Large-S Jan 27 2017 
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 Sep 24 2015 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 

More From Other Websites
Emergent BioSolutions, Inc. – Value Analysis (NYSE:EBS) : April 27, 2017 Apr 27 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : EBS-US : April... Apr 26 2017
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call... Apr 20 2017
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of... Mar 31 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : March... Mar 20 2017
Emergent BioSolutions gets $100 million anthrax contract from feds Mar 20 2017
Emergent BioSolutions Awarded $100 Million BARDA Contract for BioThrax Deliveries to the Strategic... Mar 17 2017
Local drug company stocks react to Trump's proposed cuts to NIH, FDA Mar 16 2017
Blog Coverage Galapagos Announced New Phase-II Studies Led by Filgotinib Collaboration Partner... Mar 13 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : EBS-US : March... Mar 09 2017
Emergent BioSolutions, Inc. :EBS-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Mar 02 2017
Emergent BioSolutions Inc Sets its Goal Feb 24 2017
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4 Feb 24 2017
Edited Transcript of EBS earnings conference call or presentation 23-Feb-17 10:00pm GMT Feb 23 2017
Emergent Biosolutions posts 4Q profit Feb 23 2017
Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms... Feb 23 2017
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral... Feb 13 2017
Emergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a... Feb 09 2017
Emergent BioSolutions Initiates NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum... Feb 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)